A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex).
Phase of Trial: Phase III
Latest Information Update: 18 Feb 2017
At a glance
- Drugs Triptorelin (Primary) ; Goserelin
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms EDVART
- 18 Feb 2017 Final results assessing effect of decapeptyl compared with zoladex preradiotherapy on quality of life, presented at the 2017 Genitourinary Cancers Symposium
- 17 Jun 2013 Accrual to date is 110% according to United Kingdom Clinical Research Network.
- 06 Jun 2013 Accrual to date is 98% according to United Kingdom Clinical Research Network.